Valuation China Resources Pharmaceutical Group Limited

Stocks

Market Closed - Hong Kong S.E. 01:38:20 20/10/2026 pm IST			5-day change	1st Jan Change
4.655 ^HKD	+1.09%		+6.40%	+4.61%

19/10	China Resources Pharma Unit Raises 900 Billion Yuan Via Bonds Issue	MT
01/10	China Resources Pharmaceuticals Needs More Than Distribution Scale to Win

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	22,303	39,705	32,229	35,810	27,957	29,245	-	-
Change	-	78.03%	-18.83%	11.11%	-21.93%	4.61%	-	-
Enterprise Value (EV) ¹	61,337	73,426	71,468	90,725	90,801	78,480	71,774	59,466
Change	-	19.71%	-2.67%	26.95%	0.08%	-13.57%	-8.55%	-17.15%
P/E	5.92x	9.58x	7.76x	10x	6.12x	5.97x	5.6x	5.34x
PBR	0.44x	0.8x	0.32x	0.34x	0.48x	0.45x	0.41x	0.37x
PEG	-	1x	44.15x	-0.7x	0.2x	0.83x	0.84x	1.08x
Capitalization / Revenue	0.09x	0.16x	0.12x	0.13x	0.09x	0.09x	0.09x	0.08x
EV / Revenue	0.26x	0.29x	0.27x	0.33x	0.3x	0.24x	0.21x	0.17x
EV / EBITDA	4.83x	4.38x	4.65x	5.47x	4.73x	3.94x	3.34x	2.86x
EV / EBIT	6.22x	5.39x	5.98x	6.98x	6.23x	4.87x	4.13x	3.39x
EV / FCF	5.88x	7.47x	5.49x	5.73x	4.37x	-28.9x	9.78x	6.59x
FCF Yield	17%	13.4%	18.2%	17.5%	22.9%	-3.46%	10.2%	15.2%
Dividend per Share ²	0.15	0.16	0.1669	0.1445	0.2203	0.2035	0.2202	0.218
Rate of return	4.23%	2.53%	3.25%	2.54%	4.95%	4.37%	4.73%	4.68%
EPS ²	0.6	0.66	0.6612	0.5677	0.7268	0.7794	0.8312	0.8725
Distribution rate	25%	24.2%	25.2%	25.5%	30.3%	26.1%	26.5%	25%
Net sales ¹	2,36,806	2,54,106	2,65,229	2,75,999	3,06,131	3,27,819	3,40,757	3,52,428
EBITDA ¹	12,690	16,775	15,382	16,601	19,202	19,905	21,499	20,777
EBIT ¹	9,868	13,623	11,952	13,005	14,567	16,129	17,398	17,536
Net income ¹	3,769	4,147	4,178	3,589	4,594	4,824	5,178	5,377
Net Debt ¹	39,035	33,720	39,238	54,915	62,844	49,235	42,528	30,221
Reference price ²	3.550	6.320	5.130	5.700	4.450	4.655	4.655	4.655
Nbr of stocks (in thousands)	62,82,510	62,82,510	62,82,510	62,82,510	62,82,510	62,82,510	-	-
Announcement Date	29/03/22	30/03/23	26/03/24	26/03/25	24/03/26	-	-	-

¹HKD in Million²HKD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED	5.91x	0.24x	3.93x	4.42%	368.63Cr
ELI LILLY AND COMPANY	35.75x	12.79x	26.94x	0.55%	1,10600Cr
JOHNSON & JOHNSON	37.14x	6.26x	17.62x	2.1%	61TCr
ABBVIE INC.	36.08x	8.31x	17.14x	2.43%	50TCr
ROCHE HOLDING AG	20.6x	4.98x	12.38x	2.63%	37TCr
MERCK & CO., INC.	104.7x	5.86x	25.15x	2.37%	35TCr
NOVARTIS AG	21.05x	5.51x	13.55x	2.9%	29TCr
ASTRAZENECA PLC	21.56x	4.37x	12.5x	2.02%	26TCr
AMGEN INC.	26.98x	6.96x	12.46x	2.37%	23TCr
GILEAD SCIENCES, INC.	-44.72x	6.87x	26.59x	2.15%	19TCr
Average	26.50x	6.21x	16.82x	2.4%	39.04TCr
Weighted average by Cap.	34.38x	8.10x	19.87x	1.85%